PBS
Script signature requirements will not return
Pharmaceutical Benefits Scheme (PBS) signature requirements will not return, Mark Butler, the federal Minister for Health and Aged Care says Special arrangements authorising pharmacists to sign Prescription Refund Forms on …
‘Outliers’ targeted in anti-fraud bill
One politician has taken aim at “corporate pharmacies” when discussing a bill targeting pharmacy owners who engage in fraud The National Health Amendment (Effect of Prosecution – Approved Pharmacist Corporations) …
Act now, Fiasp patients urged
Diabetes drug was set to vanish from the Australian market in days – but there’s now temporary relief for patients Patients who want to stay on the diabetes medicine Fiasp …
Continued dispensing of limited use on non-PBS items
Only those who can afford to pay will benefit from Tasmania’s new continued dispensing measures, rural pharmacists warn The program, which allows community pharmacists to provide patients with full supplies …
One Nation Bill sets pathway for cannabis PBS listing
Legislation put before the Senate this week could pave the way for medicinal cannabis products to be listed on the Pharmaceutical Benefits Scheme (PBS) Under the proposed Improving Access to …
Government targets PBS fraud loophole
Pharmacy owners convicted of defrauding the Pharmaceutical Benefits Scheme (PBS) will no longer be able to retain their Section 90 approval under proposed legislation The National Health Amendment (Effect of …
Fiasp de-listed from PBS
Diabetes patients are facing a significant increase in the cost of their medication following the government’s decision to remove Fiasp (insulin aspart injection) from the Pharmaceutical Benefits Scheme (PBS) Senator …
Extending continued dispensing ‘the right thing to do’
Enabling community pharmacists to provide patients with full supplies of their regular medications without a prescription is “the right thing to do”, Jeremy Rockliff, Tasmania’s Premier believes Under expanded continued …
PBS designed for a bygone era
Medicare reform must not come at the expense of improving other areas of Australia’s health system, including the Pharmaceutical Benefits Scheme (PBS), Trent Zimmerman, warns. Writing in The Guardian former …
Employment status impacts severe asthma expenditure
Poorly controlled asthma is placing a substantial economic burden on Australia’s healthcare system, a study reveals. Research published in Plos One found that the employment status of patients with severe or …
Medicines pricing makes Australia unattractive for manufacturers
Australia’s reliance on overseas manufactured medications combined with medicines pricing is fueling current supply shortages, a senior Guild official believes Speaking to ABC News, Adele Tahan, vice president of the …
Cost of medicines in the spotlight
Pharmacist speaks up on need for affordable medicines as Parliament debates co-pay bill The federal government has tabled its National Health Amendment (General Co-payment) Bill 2022, bringing what it says …